[HTML][HTML] Hvor mange har diabetes i Norge i 2020?
…, LA Hopstock, KI Birkeland, HL Gulseth - Tidsskrift for Den …, 2020 - tidsskriftet.no
Kåre I. Birkeland er dr. med., spesialist i endokrinologi, professor ved Institutt for klinisk
medisin, Universitetet i Oslo og overlege ved Avdeling for transplantasjonsmedisin, Oslo …
medisin, Universitetet i Oslo og overlege ved Avdeling for transplantasjonsmedisin, Oslo …
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering …
…, B Carstensen, F Persson, HL Gulseth… - The lancet Diabetes & …, 2017 - thelancet.com
Background In patients with type 2 diabetes and a high cardiovascular risk profile, the
sodium-glucose co-transporter-2 (SGLT2) inhibitors empagliflozin and canagliflozin have been …
sodium-glucose co-transporter-2 (SGLT2) inhibitors empagliflozin and canagliflozin have been …
Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with …
…, B Carstensen, HL Gulseth… - Diabetes, Obesity …, 2018 - Wiley Online Library
Aims To compare the sodium‐glucose‐cotransporter‐2 (SGLT‐2) inhibitor dapagliflozin
with dipeptidyl peptidase‐4 (DPP‐4) inhibitors with regard to risk associations with major …
with dipeptidyl peptidase‐4 (DPP‐4) inhibitors with regard to risk associations with major …
Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings
…, S Fosse-Edorh, S Fuentes, HL Gulseth… - The lancet Diabetes & …, 2021 - thelancet.com
Background Diabetes prevalence is increasing in most places in the world, but prevalence
is affected by both risk of developing diabetes and survival of those with diabetes. Diabetes …
is affected by both risk of developing diabetes and survival of those with diabetes. Diabetes …
Effects of vitamin D supplementation on insulin sensitivity and insulin secretion in subjects with type 2 diabetes and vitamin D deficiency: a randomized controlled trial
HL Gulseth, C Wium, K Angel, EF Eriksen… - Diabetes …, 2017 - Am Diabetes Assoc
OBJECTIVE In observational studies, low vitamin D levels are associated with type 2
diabetes (T2D), impaired glucose metabolism, insulin sensitivity, and insulin secretion. We …
diabetes (T2D), impaired glucose metabolism, insulin sensitivity, and insulin secretion. We …
Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data
…, YJ Cheng, H Gardiner, HL Gulseth… - The lancet Diabetes & …, 2022 - thelancet.com
Background Population-level trends in mortality among people with diabetes are inadequately
described. We aimed to examine the magnitude and trends in excess all-cause mortality …
described. We aimed to examine the magnitude and trends in excess all-cause mortality …
Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome
HL Gulseth, IMF Gjelstad, AC Tierney… - Diabetes …, 2010 - Am Diabetes Assoc
… The 25(OH)D 3 concentration was 57.1 ± 26.0 nmol/l (mean ± SD), and only 20% of the
subjects had 25(OH)D 3 levels ≥75 nmol/l. In multiple linear analyses, 25(OH)D 3 …
subjects had 25(OH)D 3 levels ≥75 nmol/l. In multiple linear analyses, 25(OH)D 3 …
Interaction between plasma fetuin‐A and free fatty acids predicts changes in insulin sensitivity in response to long‐term exercise
S Lee, F Norheim, HL Gulseth, TM Langleite… - Physiological …, 2017 - Wiley Online Library
The hepatokine fetuin‐A can together with free fatty acids ( FFA s) enhance adipose tissue (
AT ) inflammation and insulin resistance via toll‐like receptor 4 ( TLR 4). Although some of …
AT ) inflammation and insulin resistance via toll‐like receptor 4 ( TLR 4). Although some of …
Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study
…, S Fuentes, H Gardiner, HL Gulseth… - The Lancet Diabetes & …, 2022 - thelancet.com
Background Diabetes is a major public health issue. Because lifetime risk, life expectancy,
and years of life lost are meaningful metrics for clinical decision making, we aimed to estimate …
and years of life lost are meaningful metrics for clinical decision making, we aimed to estimate …
Metformin versus insulin and risk of major congenital malformations in pregnancies with Type 2 Diabetes: a nordic register-based cohort study
…, K Furu, A Engeland, M Gissler, HL Gulseth… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE To assess the risk of major congenital malformations with metformin versus
insulin in pregnancies with type 2 diabetes. RESEARCH DESIGN AND METHODS This cohort …
insulin in pregnancies with type 2 diabetes. RESEARCH DESIGN AND METHODS This cohort …
